CARISMA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.37 USD | -2.14% |
|
-9.27% | -53.24% |
| May. 09 | Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 02 | Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.670 | 2.010 | 3.110 |
| Spread/Res. | -17.96% | -31.84% | -55.95% |
| Spread/Supp. | +0.74% | +11.38% | +69.14% |
| Support | 1.360 | 1.230 | 0.8100 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CARM Stock
- Charts Carisma Therapeutics, Inc.
